The Homestake AI Act of 2026 directs the Department of Energy to launch a scientific initiative focused on sequencing the genomes of organisms found in extreme environments, such as deep mines and areas with unique heat or pressure conditions. This program aims to collect biological samples from at least five specific locations, including one deep underground mine, to build a comprehensive database that could lead to new medical treatments for diseases like cancer, diabetes, and Alzheimer's. The act mandates that all physical samples and data processing occur within the United States to prevent export, while also requiring the construction of a secure, long-term storage facility capable of surviving catastrophic events. Additionally, the legislation establishes a working group to coordinate with international allies and private sector partners to avoid duplicate efforts and create a foundation for receiving industry contributions.
This bill, known as the Dismemberment Abortion Ban Act of 2026, prohibits physicians from performing abortions that involve dismembering an unborn child piece by piece or crushing it with instruments, with the specific intent of causing the child's death. The law defines an "unborn child" as a human organism from fertilization until birth and allows for exceptions only when the procedure is necessary to save the life of the mother due to a physical disorder, illness, or injury. While it bans this specific method, the bill explicitly states that other abortion methods remain legal for reasons such as rape or incest, and it removes the previous federal ban on partial-birth abortions from the legal code. Violators face criminal penalties including fines and up to two years in prison, while women undergoing these procedures are immune from prosecution. Additionally, the bill creates a civil remedy allowing women or parents of minors to sue physicians for money damages, psychological injury, and punitive damages if the ban is violated.
The PASTEUR Act of 2026 establishes a government program to financially support the development and commercial availability of new antibiotics needed to fight drug-resistant infections. Under this bill, the Secretary of Health and Human Services can enter into contracts with pharmaceutical sponsors to provide annual payments ranging from $75 million to $300 million for drugs that treat specific resistant pathogens and address unmet medical needs. To receive these funds, companies must agree to manufacture the drugs in the United States, report resistance data, educate healthcare professionals on proper usage, and adhere to environmental best practices. The legislation also creates a new advisory group to evaluate drug applications and authorizes grant programs to help hospitals and outpatient clinics improve their antibiotic stewardship and resistance monitoring.
This Senate resolution commemorates the fourth anniversary of the 2022 Supreme Court decision in Dobbs v. Jackson Women's Health Organization, which overturned the previous federal right to abortion. The document expresses the Senate's support for state authority to regulate abortion and acknowledges the work of pregnancy centers that assist expectant mothers. It formally declares the Senate's commitment to protecting unborn life and supporting families, while noting the ongoing policy challenges related to abortion access. As a symbolic measure, the bill does not create new laws or alter existing regulations but serves to record the Senate's stance on the issue.
This resolution expresses the Senate's support for designating July 2026 as National Sarcoma Awareness Month. It aims to raise public awareness about sarcoma, a rare cancer affecting bones and connective tissues, and to encourage people to seek proper diagnosis and treatment. The bill highlights that sarcoma is often misdiagnosed and affects hundreds of thousands of individuals in the United States. By officially recognizing this month, the Senate intends to focus attention on the disease and its various subtypes.
This Senate resolution formally supports the goals and ideals of National Nurses Week, which is observed annually from May 6 to May 12, 2026. The measure recognizes the vital contributions of nurses to the healthcare system and encourages the public to acknowledge their role through ceremonies and activities during the designated week. While the bill does not create new laws or funding, it serves to honor the profession and highlight the importance of nursing in patient care and public health.
The Physical Therapist Workforce and Patient Access Act of 2026 expands the National Health Service Corps to include physical therapists, allowing them to participate in loan repayment programs to encourage practice in underserved areas. The bill directs the government to identify specific regions with shortages of physical therapy professionals and requires the collection of data to guide where these professionals are assigned. Additionally, it increases funding by $15 million to support these loan repayments and extends Medicare coverage to include physical therapy services provided at rural health clinics and federally qualified health centers starting in 2027.
This Senate resolution designates May 29, 2026, as "Mental Health Awareness in Agriculture Day" to highlight mental health issues within the farming industry. The bill aims to reduce stigma surrounding mental illness among the approximately 3.37 million agricultural producers and 1.6 million farmworkers in the United States. It acknowledges specific challenges faced by these workers, such as suicide rates that are significantly higher than the general population, and encourages the use of existing resources like the Farm and Ranch Stress Assistance Network. The resolution serves as a symbolic gesture to promote well-being rather than enacting new laws or funding changes.
This bill would remove the federal approval for the drug mifepristone, which is used in combination with other medications to end pregnancies, and would make it illegal to distribute the drug for that purpose. It also creates a new federal lawsuit option allowing individuals to sue drug manufacturers for physical or mental harm they claim resulted from using mifepristone. The law would take effect 14 days after passing, with the new lawsuit provision becoming active 90 days after enactment.
This bill, known as the Rx ACCESS Act, aims to improve medication access for military beneficiaries enrolled in the TRICARE health program by allowing them to choose how they receive non-generic prescription maintenance medications starting in October 2026. It requires pharmacy benefit managers to reimburse retail pharmacies at least the actual cost of acquiring drugs plus a professional dispensing fee, and prohibits hidden fees on pharmacies. The bill also mandates annual audits by the Government Accountability Office to review reimbursement rates, pharmacy network adequacy, and beneficiary access, with results reported to congressional defense committees.
